DOI: http://dx.doi.org/10.18203/2349-2902.isj20205877

A prospective observational study on lymph node mapping of sentinel lymph node biopsy using methylene blue in carcinoma breast

Joel John, Sansho E. U.

Abstract


Background: Modern screening methods has made it possible to diagnose breast cancer in as early stage as possible and axillary lymph node status is still the most important prognostic indicator in carcinoma breast. In this study we are trying to analyse the preference of lymph nodal staining in SLNB using methylene blue in early breast cancer, so that surgeons will be more aware of anatomical positions of the stained nodes, thus favouring more precise dissection, reducing the morbidity.

Methods: This was a prospective observational study conducted in the Department of General Surgery, Government Medical College, Kottayam. All cases of clinically N0 carcinoma breast undergoing modified radical mastectomy were included. We injected 3 ml of methylene blue in the subareolar region in three places depending on the quadrant in which tumour was situated, before putting the skin incision for modified radical mastectomy and the pathologist segregated the stained lymph nodes after confirming the anatomical locations.

Results: The study here was diagnostic test evaluation and the diagnostic test being evaluated was sentinel lymph node biopsy using methylene blue. Commonest group of lymph nodes, where sentinel lymph nodes were identified were anterior group (30 out of 34 sentinel lymph nodes).

Conclusions: Though sentinel lymph node biopsy using methylene blue is not a fool proof method; knowing the mode of methylene blue flow i.e., anterior more than central and then posterior group of lymph nodes will definitely reduce the morbidity involved, and above all saving time of the surgery.


Keywords


Anterior axillary lymph nodes, Methylene blue, Sentinel lymph nodes

Full Text:

PDF

References


Cataliotti L, Distante V, Rontini M, Ponzano C, Manetti A, Falli F. Role of axillary dissection in breast carcinoma. Chirurgia Italiana. 1995;47(4):23-31.

Rama mani L, Pai M, Kini UA. Sentinel lymph node biopsy for breast cancer using methylene blue. Int J Biol Med Res. 2014;5(1):3793-6.

Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg J Can Chir. 1993;36(4):315-20.

Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol. 1992;50(1):47-52.

Boquiren VM, Hack TF, Thomas RL, Towers A, Kwan WB, Tilley A, et al. A longitudinal analysis of chronic arm morbidity following breast cancer surgery. Breast Cancer Res Treat. 2016;157(3):413-25.

Hoe AL, Iven D, Royle GT, Taylor I. Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg. 1992;79(3):261-2.

Habal N, Giuliano AE, Morton DL. The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer. Semin Oncol. 2001;28(1):41-52.

Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg Chic. 1992;127(4):392-9.

Kissin MW, Price AB, Thompson EM, Slavin G, Kark AE. The inadequacy of axillary sampling in breast cancer. Lancet. 1982;319(8283):1210-2.

Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C. High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med. 1996;15(3):241-6.

March DE, Wechsler RJ, Kurtz AB, Rosenberg AL, Needleman L. CT pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr. 1991;15(3):440-4.

Javid S, Segara D, Lotfi P, Raza S, Golshan M. Can Breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy? Ann Surg Oncol. 2010;17(7):1841-6.

Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with (F-18) 2-deoxy-2-fluoro-D-glucose PET. Radiology. 1993;187(3):743-50.

an der Ploeg IM, Olmos RA, Kroon BB, Nieweg OE. The hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg. 2008;32(9):1930-4.

Gold HT, Do HT, Osborne MP. Cost-effectiveness of isosulfan blue vs. methylene blue dye in sentinel node biopsy. J Clin Oncol. 2005;23(16):6103.

Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002;183(1):23-7.

Uren RF, Howman-Giles R, Chung DK, Spillane AJ, Noushi F, Gillett D, et al. SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla. Breast. 2012;21(4):480-6.

Koller M, Barsuk D, Zippel DE, Engelberg S, Ben-Ari G, Papa MZ. Sentinel lymph node involvement- a predictor for axillary node status with breast cancer- has the time come? Eur J Surg Oncol. 1998;24(3):166-8.

Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001;192(6):684-9.